Cardiovascular And Respiratory Disease : A Meta Analysis Of Large Trials

Main Article Content

Mir Samim Ali , Soumi Pramanik , Shravan Kumar Paswan , Pritt Verma , Prodip Roy , Anagh Mukherjee


Objectives: Biomarkers can accurately predict a patient's risk of developing cardiovascular and respiratory diseases. The body contains substances that can act as biomarkers, or illness indicators. Novel remedies for common and unusual heart and lung diseases will be discovered through research. Methods: From January 1st to March 4th, 2020, all Oplus Heart Center Dehradun patients were included. An NHS Local Health Authority computerised hospital activity analysis register was used for this study. The ACALM study approach was then used to create a database from raw data. Result: Between January 1, 2020, and March 4, 2022, 10,259,67 patients were treated at the hospitals studied. Cardiovascular disease was more common in COPD patients than in non-COPD individuals. Soaring rates of lung cancer and pneumonitis Multivariate analysis
Conclusion: The higher risk of cardiovascular illness was associated to increased risk of death from any cause in a large cohort analysis of COPD, asthma, and idiopathic pulmonary disease (ILD). Despite these findings, patients with COPD, asthma, or ILD had lower rates of coronary revascularization operations.

Article Details